实时全球研报
The 720: KBFG & Shinhan, India Auto Parts II, China Value Retailers, Baycurrent, Samsung Biologics, Indigo, DISCO, Global Market Views, Oil
研报英文原文证据摘录
The 720: KBFG & Shinhan, India Auto Parts II, China Value Retailers, Baycurrent, Samsung Biologics, Indigo, DISCO, Global Market Views, Oil
ss Korean telcos, with subdued underlying wireless
trends offset by enterprise and data-center (AIDC) operations acting as the principal
incremental growth drivers. We raise our 12m TPs for Buy-rated KT to W74,000 and
Neutral-rated LGU to W17,000, as we see KT offering the most favorable risk-reward for
its capital-light AIDC capacity expansion, while LGU’s improving earnings quality is
balanced by valuation. We maintain our Sell rating and W58,000 12m TP on SKT, as its
sharp expected 2Q operating profit rebound largely reflects the absence of prior
data-breach costs, and its consortium-led AIDC roadmap lacks visibility on funding and
returns. Eric Cha
Life360 – 2Q26 Preview Highlights MAU Upside – Buy. Ahead of the 2Q26 results on
August 11, we leave our estimates unchanged and maintain our A$32.85 12m TP, seeing
potential upside risks to both monthly active users (MAUs) and Paying Circles. Sensor
Tower data indicates record Q2 net MAU additions of 9.4 million, implying a
re-acceleration in year-over-year growth to over 20% and presenting upside to our 4.8
million estimate. However, we note potential downside risks to profitability if this
top-of-funnel growth required higher-than-expected sales and marketing spend, and
we will also monitor the trajectory of the digital advertising business. Lindsay Bettiol
Results | Samsung Biologics, Indigo, DISCO, Newmont, United Spirits, Hyundai
Motor, Thailand Banks
Samsung Biologics – 2Q26 In Line; FY26 Revenue Tracking to Upper End – Buy. We
continue to see an attractive risk-reward profile following 2Q26 results, where revenue
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器